Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (INTEGUMENT-II)

NCT04773600 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

683

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis Eczema

Interventions

DRUG: Roflumilast Cream
DRUG: Vehicle cream

Sponsor

Arcutis Biotherapeutics, Inc.